BRUSSELS SOUTH CHARLEROIBIOPARK

THE SCIENCE-DRIVEN BIOPARK AT THE HEART OF EUROPE

500 M€

YEARLY BIOTECH DEAL FLOW

Biopark

2,000

HIGHLY SKILLED PEOPLE

Biopark

60

LIFE SCIENCE COMPANIES

Biopark

15

CLINICAL TRIALS SITES

Biopark

6

TECHNOLOGY PLATFORMS

Biopark

3

CROSS-FACULTY RESEARCH INSTITUTES

Biopark

MORE THAN 2,000 HIGHLY SKILLED PEOPLE FROM MORE THAN 30 COUNTRIES

OUR MISSION IS TO SUPPORT COMPANY GROWTH FROM INNOVATIVE START-UPS THROUGH TO GLOBAL PLAYERS

BIOPARK SKY VIEW

Testimonials

TESTIMONIALS

GREAT PLACE TO WORK

GREAT PLACE TO INVEST

GREAT PLACE TO GROW

MARGREET BROUWERSENIOR RESEARCH ASSISTANT AT Iteos Therapeutics

Testimonials

"As a former Research Assistant at ULB and now part of iTeos’ team, a biotech company headquartered here, I am delighted to see that the BioPark has attracted so many companies and people active in the life sciences sector and that it has evolved into a dynamic working environment with excellent amenities and social activities. The park’s unique cluster reinforces collaborations, stimulates knowledge sharing and creativity."

— Margreet Brouwer, Senior Research Assistant, Iteos Therapeutics

CHRIS BUYSEMANAGING PARTNER AT Fund+

Testimonials

"The BioPark’s cluster of innovative life sciences companies and their talented, multilingual and diverse work force together with the park’s state-of-the-art facilities make it an attractive place to invest. It provides an unique ecosystem of scientific, clinical and business expertise to progress early stage research and drug development through to stages offering excellent returns on investment with remarkable impact on society.”

— Chris Buyse, Managing Partner, Fund+

DENIS BEDORET PRESIDENT AT MaSTherCell Global

Testimonials

"The BioPark’s unique focus and expertise provide the perfect environment to grow your business into a fully-fledged, global company. The hands-on support we have received from the team, along with access to the BioPark’s outstanding services, have been a great help in establishing MTC as a distinguished, international cell therapy manufacturing company.”

— Denis Bedoret, President, MaSTherCell Global

WANT TO RECEIVE OUR MONTHLY NEWSLETTER?

NEWS

October 3rd 2019

Univercells boosted by EUR 20m European financing to accelerate the delivery of its vaccine portfolioEIB to lend EUR 20 million to the innovative Belgian biotechnology company, supported by the “InnovFin – EU-finance for innovators” programme. Financing to support Univercells’...

News

September 25th 2019

ULB in Gosselies: from apprehension to successMuriel Moser, Dean of the Faculty of Sciences, and Oberdan Leo, Vice-Rector in charge of research and valorisation at ULB, were among the first researchers to join the BioPark in 1999. Twenty years la...

News

EVENTS

October 30th 2019

BioPark SeminarChristophe DESMET Giga, Université de Liège "Translation regulation and quality control in hematopoiesis" Invited by Stanislas Goriely, Guillaume Oldenhove & Cyril G...

30.10.2019 / 1:30 > 2:30 PM IBMM Auditoire BRACHET / Rue Jeener et Brachet 12, 6041 GOSSELIES

Events

October 15th 2019

Comment préparer votre levée de fonds?Les Associés Deloitte & Laga ont le plaisir de vous inviter à un séminaire consacré à l’innovation. La levée de fonds sera abordée sous diff&...

15.10.2019 / 4:30 > 8:30 PM i-Tech Incubator / Rue Auguste Picard 48, 6041 Gosselies

Events